The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
暂无分享,去创建一个
Jeremy J. W. Chen | Sung-Liang Yu | G. Chang | Tsung-Ying Yang | Kun-Chieh Chen | K. Su | Chun-Shih Chin | Kuo-Hsuan Hsu | Jeng-Sen Tseng | Yen-Hsiang Huang